a developer of medical devices used for treatment of the neurological complications of diabetes
Industry MedicalSpecialties
A.I.dvisor tells us that NURO and JNDOF have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURO and JNDOF's prices will move in lockstep.
Ticker / NAME | Correlation To NURO | 1D Price Change % | ||
---|---|---|---|---|
NURO | 100% | -2.45% | ||
JNDOF - NURO | 33% Poorly correlated | N/A | ||
SGHT - NURO | 26% Poorly correlated | -5.91% | ||
RVP - NURO | 23% Poorly correlated | -4.01% | ||
ILMN - NURO | 23% Poorly correlated | -0.98% | ||
FLMNY - NURO | 22% Poorly correlated | -4.28% | ||
More |
Ticker / NAME | Correlation To NURO | 1D Price Change % |
---|---|---|
NURO | 100% | -2.45% |
diabetes theme (3 stocks) | 71% Closely correlated | -1.87% |
treatment theme (56 stocks) | 11% Poorly correlated | -1.12% |
neurological theme (10 stocks) | 2% Poorly correlated | +1.78% |
medical devices theme (60 stocks) | 1% Poorly correlated | -1.98% |
medical service theme (154 stocks) | -1% Poorly correlated | -2.06% |
More |